Super El Niño 2 in 3 chance
NOAA's Climate Prediction Center estimated a 2-in-3 chance that the developing Super El Niño event will become historically intense, peaking in winter 2026–2027.
Where this was said
Super El Niño & Hurricane Maria
At 16:36 · chapter starts 13:00
Andrew reads a real NOAA bulletin: forecasters give 2-in-3 odds of a historically intense Super El Niño peaking in winter 2026–2027, with the jet stream funneling storms directly into Southern California. This sparks a genuine science tangent on cloud overseeding — the technique of injecting excessive silver iodide particles into storm clouds to create water droplets too small to fall as rain. Andrew's take on long-term ecological consequences: the next generation can sort it out. The episode then moves into sponsor territory, with Bobby and Andrew delivering reads for NOCD — the world's leading OCD treatment provider offering virtual ERP therapy covered by insurance for over 138 million Americans — and Mountain Dew, whose American Dew limited-edition packaging they enthusiastically celebrate ahead of America's 250th birthday and the Fourth of July.
Super El Niño Is Coming for Southern California
NOAA's Climate Prediction Center puts 2-in-3 odds on this Super El Niño becoming historically intense, peaking this winter and funneling relentless storms into Southern California. Andrew Santino's proposed solution: cloud seeding in reverse, flooding the clouds with silver iodide so the droplets are too tiny to fall as rain — consequences to be sorted out by the next generation.
Similar snapshots
540M years ago: first animal vision
Animals first sensed light 540 million years ago, triggering an evolutionary acceleration known as the Cambrian explosion within 10 million years.
50% of cortex involved in vision
It is estimated that half of all cortical activity in the human brain is involved in visual function, underscoring vision's central role in intelligence.
Human 6-year-olds learn tens of thousands of object categories
Cognitive neuroscience literature shows that by age 6, humans can recognize tens of thousands of different object categories — far more data than early AI systems were trained on.
~3% of FDA drugs have unclear mechanisms
Only about 3% of FDA-approved drugs have genuinely unclear mechanisms of action, making an unknown mechanism a meaningful early red flag for any compound.
30–50% of phase 1 drugs fail to reach phase 2
Even compounds that clear preclinical testing often fail in humans: 30 to 50% of drugs entering phase 1 trials do not advance to phase 2, frequently because human behavior differs from animal models.
BPC-157 published work: >80% from one group
More than 80% of published BPC-157 research comes from a single academic group whose researchers have IP and commercial interests connected to the molecule, limiting independent replication.
~100 approved peptide drugs; ~150 in trials
Roughly 100 peptide drugs are already FDA-approved, about 150 more are in clinical trials, and 600–700 are in preclinical development, underscoring the legitimacy of peptide science broadly.
BPC-157 founder withheld screening method
The scientist who discovered BPC-157 refused to disclose the screening method used to identify the compound and has never fully published the parent protein sequence — what Peter Attia calls 'scientific trust me, bro.'
Brain barely distinguishes imagined vs real
The brain's visual, auditory, and motor cortices light up nearly identically whether an experience is real or imagined, making visualization a form of actual neural training.
